SCHEMBL5471982

SCHEMBL5471982

COc1ccc(Br)c(Oc2ccc(C#N)cc2)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 4/20 0.51
POLB P06746 1/20 0.45
GAA P10253 1/20 0.45
CYP1A1 P04798 1/20 0.44
CYP1B1 Q16678 1/20 0.44
CACNA1G O43497 1/20 0.44
CACNA1B Q00975 1/20 0.44
SLC6A4 P31645 1/20 0.42
SNCA P37840 1/20 0.42
FFAR1 O14842 1/20 0.42
HPGDS O60760 1/20 0.41
MAOA P21397 1/20 0.41
MAOB P27338 1/20 0.41
CA12 O43570 2/20 0.40
CA1 P00915 2/20 0.40
CA2 P00918 2/20 0.40
CA9 Q16790 2/20 0.40
ESRRA P11474 1/20 0.40
CA7 P43166 1/20 0.40
CA14 Q9ULX7 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8545963 0.88 PARP15 (0.45) ARPOLBCACNA1GCACNA1BSLC6A4
SCHEMBL5472622 0.87 AR (0.53) ARPOLBGAACYP1A1CYP1B1
SCHEMBL6295004 0.84 AR (0.55) ARCACNA1GCACNA1BSLC6A4FFAR1
SCHEMBL17472498 0.80 LTA4H (0.55) POLBGAACYP1A1CYP1B1CA12
SCHEMBL5475789 0.79 AR (0.50) ARPOLBGAACYP1A1CYP1B1
SCHEMBL27438050 0.79 AR (0.60) ARPOLBGAACYP1A1CYP1B1
SCHEMBL2788214 0.77 AR (0.55) ARPOLBGAACACNA1GCACNA1B
SCHEMBL921496 0.77 MAOA (0.56) ARPOLBGAACACNA1GCACNA1B
SCHEMBL30376409 0.75 AR (0.51) ARPOLBSLC6A4HPGDSCA12
SCHEMBL8546604 0.75 AR (0.51) ARPOLBGAACACNA1GCACNA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070093548-A1 Use of progesterone receptor modulators WYETH (US) 2007-04-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070093548-A1 Use of progesterone receptor modulators PGR, GNRHR, PGRMC2 AR 104/4885POLB 1501/4885GAA 4818/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.